Precision BioSciences Reports Q3 Loss
Precision BioSciences reported a loss for the third quarter.
Related stories
CVR Energy Announces Proposed $750 Million Common Stock Offering
CVR Energy is offering $500 million of shares in an underwritten public offering, alongside a sale by IEP Energy Holding LLC.
M impact | EQUITY | Nov 03, 2026, 01:21 PM UTC
Vitroscope Raises $7M to Scale Live-Tissue Platform
Vitroscope raised $7 million. Cerberus Ventures and YZR Capital co-led a $5 million seed round, alongside $2 million in non-dilutive funding.
L impact | EQUITY | Nov 03, 2026, 01:21 PM UTC
Opera Q3 Revenue Rises on Desktop User Growth
M impact | EQUITY | Nov 03, 2026, 01:21 PM UTC
ADM Reports Q3 EPS of $1.70, Raises 2026 Guidance
Third-quarter 2026 net earnings were $821 million, versus $108 million a year earlier; adjusted EPS was $1.77, up from $0.92. ADM raised 2026 adjusted EPS guidance to approximately
M impact | EQUITY | Nov 03, 2026, 01:20 PM UTC
Knife River Q3 Earnings Fall as Revenue Rises; Cuts 2026 Revenue Guidance
Knife River reported Q3 net income of $2.43 and trimmed its 2026 revenue guidance.
M impact | EQUITY | Nov 03, 2026, 01:20 PM UTC
Dynacor Secures $20 Million Gold Purchase and Prepayment Facility
Dynacor entered into a gold purchase and prepayment facility with Auramet.
M impact | EQUITY | Nov 03, 2026, 01:19 PM UTC